SCHEMBL244118

SCHEMBL244118

CNc1ccccc1[C]=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.43
POLB P06746 3/20 0.43
TDP1 Q9NUW8 3/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
MAPT P10636 2/20 0.43
ALDH1A1 P00352 2/20 0.43
RECQL P46063 2/20 0.43
USP2 O75604 1/20 0.43
HPGD P15428 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
HSD17B10 Q99714 1/20 0.43
ATM Q13315 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.39
RAB9A P51151 3/20 0.39
EGFR P00533 1/20 0.39
PABPC1 P11940 1/20 0.39
MAPK1 P28482 1/20 0.39
HTR6 P50406 1/20 0.39
TSHR P16473 2/20 0.35
IDO1 P14902 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3878150 0.80 KDM4E (0.33) KDM4ETDP1L3MBTL1MAPTALDH1A1
SCHEMBL115146 0.76 CA12 (0.43) KDM4EPOLBTDP1L3MBTL1MAPT
SCHEMBL1343863 0.76 KDM4E (0.52) KDM4EPOLBTDP1L3MBTL1MAPT
SCHEMBL29565140 0.76 KDM4E (0.52) KDM4EPOLBTDP1L3MBTL1MAPT
SCHEMBL10430895 0.76 POLB (0.43) KDM4EPOLBTDP1L3MBTL1MAPT
SCHEMBL5535596 0.76 IDO1 (0.40) KDM4EPOLBTDP1L3MBTL1MAPT
SCHEMBL3398377 0.76 GAA (0.37) KDM4EPOLBTDP1L3MBTL1MAPT
SCHEMBL7273614 0.76 TDP1 (0.41) KDM4ETDP1L3MBTL1MAPTALDH1A1
SCHEMBL2757856 0.74 MAPT (0.41) KDM4EPOLBTDP1L3MBTL1MAPT
SCHEMBL29948831 0.74 MAPT (0.41) KDM4EPOLBTDP1L3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 418 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024074585-A2 MICROPARTICLE AND IMPLANT FORMULATIONS FOR cGMP ANALOG THERAPY MIRECA MEDICINES GMBH (DE) 2024-04-11 WO claimed
US-20230242568-A1 POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES MIRECA MEDICINES GMBH (DE) 2023-08-03 US claimed
CN-115161300-A Aquilaria sinensis-derived III-type polyketide synthase AsPKS3 and coding gene and application thereof 中国医学科学院药用植物研究所 2022-10-11 CN claimed
CN-115011576-A Aquilaria sinensis-derived III-type polyketide synthase AsPKS5, and coding gene and application thereof 中国医学科学院药用植物研究所 2022-09-06 CN claimed
CN-114990084-A Aquilaria sinensis-derived III-type polyketide synthase AsPKS4, and coding gene and application thereof 中国医学科学院药用植物研究所 2022-09-02 CN claimed
US-11371938-B2 Nanomaterial-based bacterial sensors AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2022-06-28 US claimed
US-20210317156-A1 NEW POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES MIRECA MEDICINES GMBH (DE) 2021-10-14 US claimed
US-11001605-B2 Cyclic dinucleotides containing benzimidazole, method for the production of same, and use of same to activate stimulator of interferon genes (sting)-dependent signaling pathways BIOLOG LIFE SCIENCE INSTITUTE GMBH & CO. KG (DE) 2021-05-11 US claimed
US-20200182889-A1 CHEMILUMINESCENT BIOSENSOR FOR DETECTING COAGULATION FACTORS LEE JI HOON (US) 2020-06-11 US claimed
US-20200158642-A1 Nanomaterial-based Bacterial Sensors AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2020-05-21 US claimed
CN-1323209-A Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase SCIOS INC (US) 2001-11-21 CN claimed
EP-1107758-A2 USE OF PIPERIDINES AND/OR PIPERAZINES AS INHIBITORS OF P38-ALPHA KINASE SCIOS INC. (US) 2001-06-20 EP claimed
WO-2000075306-A2 METHOD FOR PRODUCING DOUBLE STRANDED POLYNUCLEOTIDES CYCLOPS GENOME SCIENCES LIMITED (GB) 2000-12-14 WO claimed
WO-2000066605-A2 POLYNUCLEOTIDES CYCLOPS GENOME SCIENCES LIMITED (GB) 2000-11-09 WO claimed
EP-1001943-A1 POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM Aventis Pharma S.A. (FR) 2000-05-24 EP claimed
WO-2000012074-A2 USE OF PIPERIDINES AND/OR PIPERAZINES AS INHIBITORS OF P38-ALPHA KINASE SCIOS INC. (US) 2000-03-09 WO claimed
WO-1999042435-A2 MYXOCHELINES ANALYTICON AG BIOTECHNOLOGIE PHARMAZIE (DE) 1999-08-26 WO claimed
WO-1999003843-A1 POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM RHONE-POULENC RORER S.A. (FR) 1999-01-28 WO claimed
US-4908204-A Reversibly blocked plasmin, t-PA hybrid fibrinolytic enzymes and pharmaceutical compositions and anti-thrombotic use thereof BEECHAM GROUP P.L.C. (GB) 1990-03-13 US claimed
EP-0155387-B1 FIBRONOLYTICALLY ACTIVE HYBRID PROTEIN, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION BEECHAM GROUP PLC (GB) 1989-09-06 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242568-A1 POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES PRKG1, PRKG2, PRKAG3 KDM4E 598/4885POLB 1465/4885TDP1 669/4885
US-11001605-B2 Cyclic dinucleotides containing benzimidazole, method for the production of same, and use of same to activate stimulator of interferon genes (sting)-dependent signaling pathways STING1, MAVS, CGAS KDM4E 4243/4885POLB 161/4885TDP1 569/4885
US-20210317156-A1 NEW POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES PRKG1, PRKG2, PDE7A KDM4E 638/4885POLB 1528/4885TDP1 690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.